Live Breaking News & Updates on Philipl johnson

Stay informed with the latest breaking news from Philipl johnson on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Philipl johnson and stay connected to the pulse of your community

Jazz Pharmaceuticals (JAZZ) Set to Announce Earnings on Wednesday

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $3.55 per share for the quarter. Jazz Pharmaceuticals has set its FY24 guidance at $18.15-$19.35 EPS and its FY 2024 guidance at 18.150-19.350 […]

United-states , Piper-sandler , Patricia-carr , Philipl-johnson , Stifel-nicolaus , News-ratings-for-jazz-pharmaceuticals-daily , Jazz-pharmaceuticals , Jazz-pharmaceuticals-price-performance , Earnings-history-for-jazz-pharmaceuticals , Needham-company , Barclays , Securities-exchange-commission

Eukles Asset Management Sells 144 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Eukles Asset Management reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,180 shares of the specialty pharmaceutical company’s stock after selling 144 shares during the quarter. Eukles Asset Management’s holdings […]

Canada , Wellington , New-zealand-general- , New-zealand , United-states , Robertw-baird , Philipl-johnson , Patricia-carr , Royal-bank , Jazz-pharmaceuticals , Needham-company , Securities-exchange-commission

Eukles Asset Management Reduces Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Eukles Asset Management trimmed its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,180 shares of the specialty pharmaceutical company’s stock after selling 144 shares during the period. Eukles […]

United-states , Patricia-carr , Piper-sandler , Stifel-nicolaus , Philipl-johnson , Covestor-ltd , Jazz-pharmaceuticals-price-performance , News-ratings-for-jazz-pharmaceuticals-daily , Insider-activity-at-jazz-pharmaceuticals , Quarter-for-jazz-pharmaceuticals , Needham-company , Cantor-fitzgerald

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Kendall Capital Management

Kendall Capital Management boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,799 shares of the specialty pharmaceutical company’s stock after purchasing an additional 1,795 shares […]

United-states , Philipl-johnson , Robertw-baird , Patricia-carr , Needham-company , Barclays , Vanguard-group-inc , Jazz-pharmaceuticals , Aviva-plc , News-ratings-for-jazz-pharmaceuticals-daily , Jpmorgan-chase-co , Exchange-commission

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kendall Capital Management

Kendall Capital Management grew its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 7,799 shares of the specialty pharmaceutical company’s stock after buying an additional 1,795 shares during the quarter. Kendall Capital Management’s holdings in Jazz Pharmaceuticals were worth $959,000 […]

Wellington , New-zealand-general- , New-zealand , Canada , United-states , Patricia-carr , Stifel-nicolaus , Philipl-johnson , Jazz-pharmaceuticals-company-profile , Nasdaq , Jpmorgan-chase-co , News-ratings-for-jazz-pharmaceuticals-daily

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns "Overweight" Rating from Cantor Fitzgerald

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earns "Overweight" Rating from Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Philipl-johnson , Piper-sandler , Patricia-carr , Barclays , Cantor-fitzgerald , News-ratings-for-jazz-pharmaceuticals-daily , Jazz-pharmaceuticals-stock-down , Covestor-ltd , St-germaindj-co , Analyst-recommendations-for-jazz-pharmaceuticals , Cape-investment-advisory-inc

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $195.08 Average Price Target from Brokerages

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The […]

United-states , Canada , Wellington , New-zealand-general- , New-zealand , Patricia-carr , Robertw-baird , Stifel-nicolaus , Philipl-johnson , Wellington-management-group , Jazz-pharmaceuticals-company-profile , Analyst-recommendations-for-jazz-pharmaceuticals

Jazz Pharmaceuticals plc to Post Q1 2024 Earnings of $3.24 Per Share, Zacks Research Forecasts (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc to Post Q1 2024 Earnings of $3.24 Per Share, Zacks Research Forecasts (NASDAQ:JAZZ)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Utah , United-states , Philipl-johnson , Patricia-carr , Institutional-trading-of-jazz-pharmaceuticals , Jazz-pharmaceuticals-company-profile , Daiwa-securities-group-inc , Waterfront-wealth-inc , Zacks-research , Barclays , Jazz-pharmaceuticals-trading-down , News-ratings-for-jazz-pharmaceuticals-daily

Research Analysts Set Expectations for Jazz Pharmaceuticals plc's Q1 2024 Earnings (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Investment analysts at Zacks Research decreased their Q1 2024 earnings estimates for shares of Jazz Pharmaceuticals in a research note issued to investors on Wednesday, March 20th. Zacks Research analyst S. Ganoria now anticipates that the specialty pharmaceutical company will post earnings per share of $3.24 for […]

Canada , United-states , Blackrock , New-zealand-general- , New-zealand , Wellington , Patricia-carr , Philipl-johnson , Robertw-baird , Stifel-nicolaus , Blackrock-inc , Vanguard-group-inc

Tributary Capital Management LLC Lowers Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Tributary Capital Management LLC decreased its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,490 shares of the specialty pharmaceutical company’s stock after selling 100 shares during the quarter. Tributary Capital […]

United-states , Patricia-carr , Robertw-baird , Philipl-johnson , Us-bancorp , Jazz-pharmaceuticals-stock-performance , Securities-exchange-commission , Tributary-capital-management , Quarter-for-jazz-pharmaceuticals , Jpmorgan-chase-co , Advisor-group , Jazz-pharmaceuticals